A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2001-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.V62N1107PMID 11775047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effect of Extract of Ginkgo Biloba Added to Haloperidol on Superoxide Dismutase in Inpatients With Chronic Schizophrenia

  2001cited by this paper
• Abnormal age-related changes of plasma antioxidant proteins in schizophrenia.

  2000cited by this paper
• Elevated plasma lipid peroxides at the onset of nonaffective psychosis.

  1998cited by this paper
• Free radical pathology in schizophrenia: a review.

  1996cited by this paper
• Free radical pathology and antioxidant defense in schizophrenia: a review.

  1996cited by this paper
• Oxidative injury and potential use of antioxidants in schizophrenia.

  1996cited by this paper
• Free radical involvement in neuropsychiatric illnesses.

  1995cited by this paper
• Risperidone: new horizons for the schizophrenic patient. 9th World Congress of Psychiatry of the World Psychiatric Association, Rio de Janeiro, June 1993.

  1994cited by this paper
• Free radical mechanisms in schizophrenia and tardive dyskinesia.

  1994cited by this paper
• Ginkgo biloba for cerebral insufficiency.

  1992cited by this paper
• Enzymes of the antioxidant defense system in chronic schizophrenic patients.

  1991cited by this paper
• A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment.

  1991cited by this paper
• Oxygen radicals and neuropsychiatric illness. Some speculations.

  1991cited by this paper
• Haloperidol and reduced haloperidol concentrations and psychiatric ratings in schizophrenic patients treated with ascorbic acid.

  1989cited by this paper
• An adjunctive role for ascorbic acid in the treatment of schizophrenia?

  1987cited by this paper
• Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients.

  1986cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Non-Clozapine interventions in treatment-resistant schizophrenia: a systematic review and meta-analysis

  2025cites this paper
• Herb‐drug interactions: A short review on central and peripheral nervous system drugs

  2024cites this paper
• Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

  2023cites this paper
• Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment

  2023cites this paper
• Ginkgo biloba Extracts Like EGb 761 ® for Treatment of Non Common Indications – A Selection of Clinical Studies

  2023cites this paper
• Creating the optimal diet: Diet can reduce the symptoms of schizophrenia

  2022cites this paper
• Diagnostic Performance of Increased Malondialdehyde Level and Oxidative Stress in Patients with Schizophrenia

  2021cites this paper
• Traditional Chinese Medicine Decoction Combined With Antipsychotic for Chronic Schizophrenia Treatment: A Systematic Review and Meta-analysis

  2021cites this paper
• Antipsychotic natural products

  2020cites this paper
• Effect of herbal and nutritional products on the central nervous system effects of haloperidol: a systematic review

  2019cites this paper
• Natural Medicines for Psychotic Disorders

  2018cites this paper
• OXYTOCIN ADMINISTRATION IMPROVES MEMORY, ANXIETY AND SOME OXIDATIVE STRESS PARAMETERS IN A METHIONINEINDUCED RAT MODEL OF SCHIZOPHRENIA

  2018cites this paper
• Neuroprotection in Schizophrenia and Its Therapeutic Implications

  2017cites this paper
• Crosstalk between endoplasmic reticulum stress and oxidative stress in schizophrenia: The dawn of new therapeutic approaches

  2017cites this paper
• HERB-DRUG INTERACTIONS: AN OVERVIEW OF MECHANISMS AND CLINICAL ASPECTS

  2016cites this paper
• Ginkgo biloba and vitamin E ameliorate haloperidol-induced vacuous chewingmovement and brain-derived neurotrophic factor expression in a rat tardive dyskinesia model.

  2016cites this paper
• Beneficial effects of EGb761 and vitamin E on haloperidol-induced vacuous chewing movements in rats: Possible involvement of S100B mechanisms.

  2016cites this paper
• Antioxidant treatments for schizophrenia.

  2016cites this paper
• Ginkgo biloba Extract 761: A Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders.

  2015cites this paper
• The interplay between BDNF and oxidative stress in chronic schizophrenia.

  2015cites this paper
• Efficacy and safety of extract of Ginkgo biloba as an adjunct therapy in chronic schizophrenia: A systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis.

  2015cites this paper
• Inflammation in schizophrenia: A question of balance.

  2015cites this paper
• Polypharmacy in Older Adults.

  2015cites this paper
• Integrative and Complementary Medicine in Psychiatry

  2015cites this paper
• Tardive dyskinesia (syndrome): Current concept and modern approaches to its management

  2015cites this paper
• An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia

  2015cites this paper
• The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases

  2014cites this paper
• Direct correlation between the scores of PANSS/AIMS scales and some oxidative stress markers in treated schizophrenic patients

  2014influential citation
• Natural Medicines in Schizophrenia: A Systematic Review

  2014cites this paper
• Refining and integrating schizophrenia pathophysiology - relevance of the allostatic load concept.

  2014cites this paper
• Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics

  2014cites this paper
• Haloperidol versus placebo for schizophrenia.

  2013cites this paper
• Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study.

  2013cites this paper
• A Systematic Review and Meta-Analysis of Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day Medicine

  2013influential citation
• Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.

  2013cites this paper
• Antipsychotic-Like Effect of Trimetazidine in a Rodent Model

  2013cites this paper
• EFFECTS OF PORTULACA OLERACEA L (PURSLANE) ON PSYCHOLOGICAL SYMPTOMS OF CHRONIC SCHIZOPHRENIC PATIENTS IN SINA HOSPITAL

  2013cites this paper
• Pharmacological approaches to treating negative symptoms: a review of clinical trials.

  2013cites this paper
• The clinician's role in assessing for drug-induced movement disorders: Practices at a forensic psychiatric hospital

  2012cites this paper
• EFFECT OF GINKGO BILOBA, RISPERIDONE AND BIPERIDEN REGIMEN IN CHRONIC SCHIZOPHRENIA

  2012cites this paper
• Plasma total antioxidant status and cognitive impairments in schizophrenia.

  2012cites this paper
• Cortical interneurons, immune factors and oxidative stress as early targets for schizophrenia

  2012cites this paper
• Herb-Drug Interactions

  2012cites this paper
• Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.

  2012cites this paper
• Oxidative stress in schizophrenia - focusing on the main markers.

  2011cites this paper
• Oxidative stress in schizophrenia: an integrated approach.

  2011cites this paper
• Inhibition of ketamine‐induced hyperlocomotion in mice by the essential oil of Alpinia zerumbet: possible involvement of an antioxidant effect

  2011cites this paper
• Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia.

  2011cites this paper
• Treatment resistant schizophrenia and response to antipsychotics: a review.

  2011cites this paper
• A An Insight into Herb-Drug Interactions

  2011cites this paper
• Motor Symptoms of Schizophrenia: Is Tardive Dyskinesia a Symptom or Side Effect? A Modern Treatment

  2011influential citation
• Advancing Neuroprotective-Based Treatments for Schizophrenia

  2011cites this paper
• Antioxidants as a Treatment and Prevention of Tardive Dyskinesia

  2011cites this paper
• systematic review of randomised trials Chinese herbal medicine for schizophrenia : Cochrane

  2011cites this paper
• Journal of Complementary and Integrative Medicine Complementary and Alternative Medicine in Psychotic Disorders

  2011cites this paper
• Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial.

  2011cites this paper
• Interactions between Herbs used for Cardiovascular Disorders and Drugs

  2011cites this paper
• Research in people with psychosis risk syndrome: a review of the current evidence and future directions.

  2010cites this paper
• Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia.

  2010influential citation
• Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics.

  2010cites this paper
• Drug Interactions with Ginkgo Biloba and Ginseng

  2010cites this paper
• The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients.

  2009cites this paper
• Orthomolecular and Botanical Treatments to Help Alleviate the Side Effects of Atypical Antipsychotic Drugs

  2009cites this paper
• Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines.

  2009cites this paper
• Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile

  2009cites this paper
• A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia

  2008influential citation
• Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.

  2008cites this paper
• Glutathione: a novel treatment target in psychiatry.

  2008cites this paper
• Interações entre fármacos e medicamentos fitoterápicos à base de ginkgo ou ginseng

  2008cites this paper
• Le traitement des formes déficitaires de schizophrénie

  2007cites this paper
• Review Article Neuroprotection in emerging psychotic disorders

  2007cites this paper
• Chinese herbal medicine for schizophrenia: cochrane systematic review of randomised trials.

  2007cites this paper
• Neuroprotection in emerging psychotic disorders

  2007cites this paper
• Evidence-based drug--herbal interactions.

  2006influential citation
• Ethnicity and use of alternative products in psychiatric patients.

  2006cites this paper
• Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.

  2006cites this paper
• Treatment Resistance in Schizophrenia: The Role of Alternative Therapies

  2006cites this paper
• Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study.

  2006cites this paper
• Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review.

  2006cites this paper
• The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial

  2006influential citation
• Imbalanced free radicals and antioxidant defense systems in schizophrenia: A comparative study

  2006cites this paper
• Clinical Drug Interactions with Medicinal Herbs

  2005cites this paper
• Lack of herbal supplement characterization in published randomized controlled trials.

  2005cites this paper
• Experience is a biochemical intervention: reconceptualizing the "biologically based mental illness".

  2005cites this paper
• Emerging issues in traditional Chinese medicine.

  2005cites this paper
• Chinese herbal medicine for schizophrenia.

  2005cites this paper
• “Stress‐alleviating” and “vigilance‐enhancing” actions of Ginkgo biloba extract (EGb 761)

  2004cites this paper
• Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders.

  2004cites this paper
• Herbals and botanicals in geriatric psychiatry.

  2003cites this paper
• Behavioural and psychological symptoms of dementia (BPSD): effects of EGb 761.

  2003cites this paper
• Extract of Ginkgo biloba added to haloperidol was effective for positive symptoms in refractory schizophrenia

  2002cites this paper
• Current Awareness in Human Psychopharmacology

  2002cites this paper
• Current Awareness in Human Psychopharmacology

  2002cites this paper